Williams E D
Department of Histopathology, University of Cambridge, Addenbrookes Hospital, UK.
Mutat Res. 1995 Dec;333(1-2):123-9. doi: 10.1016/0027-5107(95)00138-7.
The transformation of the normal fully differentiated thyroid follicular cell to the rapidly growing undifferentiated anaplastic thyroid carcinoma cell involves a number of stages which have been defined morphologically and are now being related to various growth pathways and to molecular biological defects. The two main factors involved in this transformation are growth stimulation and mutagenesis. Growth stimulation alone, through elevated TSH, can lead to the development of thyroid tumours, usually benign, and retaining TSH dependency in some cases. Mutagens alone, if growth is suppressed, do not produce tumours, the combination of mutagens and increased growth is a potent carcinogenic regime. Non-genotoxic carcinogenesis in the thyroid involves growth, without mutagenesis the agent often causes this through affecting one component of thyroid hormone synthesis or metabolism, leading to a fall in thyroid hormone levels and a rise in TSH. Growth stimulation increases the rate of cell division, and therefore increases the chance of a mutation. Continued growth increases the change of subsequent events, in particular loss of heterozygosity in a tumour suppressor gene. The main oncogenes involved in human thyroid carcinogens are ras in the follicular tumour pathway, and ret in the papillary carcinoma pathway. p53 is involved in the progression of either papillary or follicular adenoma to an undifferentiated carcinoma. In experimental thyroid carcinogenesis, ras is again involved, with a link between the mutagenic agent used and the type of ras gene showing mutation. Analysis of the involvement of different growth factors and oncogenes in thyroid carcinogenesis suggests that genes related to the two receptors concerned with normal TSH stimulated growth, TSH receptor and the IGF1 receptor may be involved in the progression of thyroid tumours of follicular pathology. Several tyrosine kinase receptors with unknown ligands or of uncertain physiological function are linked to papillary carcinoma. The recent large increase in papillary carcinoma of the thyroid in children exposed to fallout from the Chernobyl nuclear accident underlines the importance of understanding the pathobiology of thyroid neoplasia.
正常的完全分化甲状腺滤泡细胞转变为快速生长的未分化间变性甲状腺癌细胞涉及多个阶段,这些阶段已通过形态学定义,目前正与各种生长途径及分子生物学缺陷相关联。参与这种转变的两个主要因素是生长刺激和诱变。仅生长刺激,通过升高的促甲状腺激素(TSH),可导致甲状腺肿瘤的发生,通常为良性,且在某些情况下保持对TSH的依赖性。单独的诱变剂,如果生长受到抑制,则不会产生肿瘤,诱变剂与生长增加的组合是一种强大的致癌机制。甲状腺中的非遗传毒性致癌作用涉及生长,该因子通常通过影响甲状腺激素合成或代谢的一个成分而在无诱变的情况下导致这种情况,从而导致甲状腺激素水平下降和TSH升高。生长刺激增加细胞分裂速率,因此增加了发生突变的机会。持续生长增加了后续事件的可能性,特别是肿瘤抑制基因杂合性的丧失。人类甲状腺致癌物中涉及的主要癌基因在滤泡性肿瘤途径中是ras,在乳头状癌途径中是ret。p53参与乳头状或滤泡性腺瘤向未分化癌的进展。在实验性甲状腺致癌作用中,ras再次涉及,所用诱变剂与显示突变的ras基因类型之间存在联系。对不同生长因子和癌基因参与甲状腺致癌作用的分析表明,与正常TSH刺激生长相关的两种受体(TSH受体和IGF1受体)相关的基因可能参与滤泡性病理甲状腺肿瘤的进展。几种配体未知或生理功能不确定的酪氨酸激酶受体与乳头状癌有关。切尔诺贝利核事故辐射暴露儿童中甲状腺乳头状癌近期的大幅增加凸显了理解甲状腺肿瘤病理生物学的重要性。